Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid

Medical Hypotheses

Volumn 74, Issue 4, 2010, Pages 727-728

  Toosi, Siavash ^a   Bystryn, Jean Claude ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNE DISEASE; BLISTER; BULLOUS PEMPHIGOID; CELL INFILTRATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHIL; HUMAN; INNATE IMMUNITY; NEUTROPHIL CHEMOTAXIS; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BASEMENT MEMBRANE; BLISTER; CELL ADHESION MOLECULES; CYTOKINES; EOSINOPHILS; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; IMMUNOLOGIC TESTS; INTERLEUKIN-17; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; NEUTROPHILS; PEMPHIGOID, BULLOUS; SKIN; SKIN DISEASES, VESICULOBULLOUS;

EID: 77649340785     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.10.038     Document Type: Article

References (30)

1. Di Zenzo G., Marazza G., and Borradori L. Bullous pemphigoid: physiopathology, clinical features and management. Adv Dermatol 23 (2007) 257-288
2. Kasperkiewicz M., and Zillikens D. The pathophysiology of bullous pemphigoid. Clin Rev Allergy Immunol 33 1-2 (2007) 67-77
3. Wong M.M., Giudice G.J., and Fairley J.A. Autoimmunity in bullous pemphigoid. G Ital Dermatol Venereol 144 4 (2009) 411-421
4. D'Auria L., Cordiali Fei P., and Ameglio F. Cytokines and bullous pemphigoid. Eur Cytokine Netw 10 2 (1999) 123-134
5. Miossec P., Korn T., and Kuchroo V.K. Interleukin-17 and type 17 helper T cells. New Engl J Med 361 9 (2009) 888-898
6. Barlow J.L., and McKenzie A.N. IL-25: a key requirement for the regulation of type-2 immunity. Biofactors 35 2 (2009) 178-182
7. Volpe E., Servant N., Zollinger R., et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9 6 (2008) 650-657
8. Miossec P. IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect 11 5 (2009) 625-630
9. Pernis A.B. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med 265 6 (2009) 644-652
10. Annunziato F., Cosmi L., Liotta F., Maggi E., and Romagnani S. Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 5 6 (2009) 325-331
11. Basso A.S., Cheroutre H., and Mucida D. More stories on Th17 cells. Cell Res 19 4 (2009) 399-411
12. Korn T., Bettelli E., Oukka M., and Kuchroo V.K. IL-17 and Th17 Cells. Annu Rev Immunol 27 (2009) 485-517
13. Fouser L.A., Wright J.F., Dunussi-Joannopoulos K., and Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 226 (2008) 87-102
14. Wakashin H., Hirose K., Iwamoto I., and Nakajima H. Role of IL-23-Th17 cell axis in allergic airway inflammation. Int Arch Allergy Immunol 149 Suppl. 1 (2009) 108-112
15. Arakawa M., Dainichi T., Yasumoto S., and Hashimoto T. Lesional Th17 cells in pemphigus vulgaris and pemphigus foliaceus. J Dermatol Sci 53 3 (2009) 228-231
16. Yasukawa S., Dainichi T., Kokuba H., et al. Bullous pemphigoid followed by pustular psoriasis showing Th1, Th2, Treg and Th17 immunological changes. Eur J Dermatol 19 1 (2009) 69-71
17. Lambiase A., Micera A., Mantelli F., et al. T-helper 17 lymphocytes in ocular cicatricial pemphigoid. Mol Vis 15 (2009) 1449-1455
18. Wang Y.H., and Liu Y.J. The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol 20 6 (2008) 697-702
19. Andoh A., Yasui H., Inatomi O., et al. Interleukin-17 augments tumor necrosis factor-alpha-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblasts. J Gastroenterol 40 (2005) 802-810
20. Fossiez F., Djossou O., Chomarat P., et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183 (1996) 2593-2603
21. Yao Z., Fanslow W.C., Seldin M.F., et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3 (1995) 811-821
22. Laan M., Cui A.H., Hoshino H., et al. Neutrophil recruitment by human IL-17 via CXC chemokine release in the airways. J Immunol 162 (1999) 2347-2352
23. Jovanovic D.V., Martel-Pelletier J., Di Battista J.A., et al. Stimulation of 92-kd gelatinase production by interleukin-17 in human monocyte/macrophages. Arthritis Rheum 43 (2000) 1134-1137
24. Rifas S., and Arackal S. T cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism. Arthritis Rheum 48 (2003) 993-1001
25. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
26. Liu Z., Giudice G.J., Zhou X., et al. A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest 100 (1997) 1256-1263
27. Annunziato F., Cosmi L., Santarlasci V., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 204 8 (2007) 1849-1861
28. Zhang R., Qian J., Guo J., Yuan Y.F., and Xue K. Suppression of experimental autoimmune uveoretinitis by anti-IL-17 antibody. Curr Eye Res 34 4 (2009) 297-303
29. Lubberts E., Koenders M.I., Oppers-Walgreen B., et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50 2 (2004) 650-659
30. Pene J., Gauchat J.F., Lécart S., et al. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J Immunol 172 (2004) 5154-5157